A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...

As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...

Cell and gene therapies (CGTs) are revolutionizing the landscape of personalized medicine, offering treatments that were once ...

In June, the Centers for Medicare & Medicaid Services (CMS) will name the participating states for the agency’s new Cell and ...

Innovative financing and reimbursement models can improve access to cell and gene therapies, addressing cost barriers and ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation ...

Forge Biologics ("Forge"), a leading manufacturer of genetic medicines and member of the Ajinomoto Bio-Pharma Services group, ...

Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...

A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life ...

Future treatments for DEB are expected to drive the sector’s growth. The global dermatological cell and gene therapy (CGT) ...

A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.